Bipolar Disorder Trial, Recruiting NCT07619092 Sponsor: Anders Jørgensen Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07619092
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are currently experiencing a depressive episode (whether related to depression alone or bipolar disorder)
  • You are currently admitted to a participating department within the Mental Health Services of the Capital Region of Denmark
  • Your psychiatrist has referred you for ECT (electroconvulsive therapy) and you have agreed to receive it
  • You are currently taking a benzodiazepine (a type of sedative/anxiety medication) and/or zopiclone (a sleeping medication) at or above a certain minimum daily dose

Who may not be able to join:

  • You are being required to have ECT against your will (involuntary treatment)
  • You have a known significant structural problem with the brain that is likely to affect memory or thinking
  • You are pregnant or currently breastfeeding
  • You are unable to read or understand Danish
  • You currently have an acute brain condition, such as severe confusion (delirium), that would prevent you from giving informed consent
  • You have a condition that increases the risk of prolonged or uncontrollable seizures, such as epilepsy, or you are going through withdrawal from alcohol or sedative medications
  • You have a condition that affects how your body processes a medication called flumazenil, such as liver failure (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anders Jørgensen, MD, Ph.D., Mental Health Services of the Capital Region

Phone: + 45 21 35 40 55

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anders Jørgensen
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
1 August 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Screen for Cognitive Impairment in Psychiatry (SCIP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov